CSX Financial Statements & Analysis
Complete financial statements for CSX including income statement, balance sheet, and cash flow statement. Analyze CSX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
49
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
-0.8% ↓
Net Income
-5.4% ↓
Gross Margin
-0.9% ↓
Operating Margin
-1.1% ↓
Balance Sheet
Current Ratio
-17.4% ↓
Debt to Equity
-4.4% ↑
Asset Turnover
-2.1% ↓
Cash Flow
Operating Cash Flow
-5.4% ↓
Net Cash Flow
30.6% ↑
Free Cash Flow
-16.8% ↓
Cash Flow to Debt
-5.3% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 14.66B | 14.54B | 0.8% | |
| Gross Profit | 5.60B | 5.51B | 1.7% | |
| Operating Income | 5.47B | 5.37B | 1.8% | |
| Net Income | 3.67B | 3.47B | 5.4% | |
| EPS | 1.85 | 1.79 | 3.2% | |
| EBITDA | 7.27B | 7.07B | 2.8% | |
| Gross Margin | 38.23% | 37.87% | 0.9% | |
| Operating Margin | 37.30% | 36.91% | 1.1% | |
| Net Income Margin | 25.03% | 23.87% | 4.6% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 14.54B | 14.66B | 14.85B | 12.52B | 10.58B |
| Gross Profit | 5.51B | 5.60B | 5.93B | 5.29B | 4.44B |
| Operating Income | 5.37B | 5.47B | 5.79B | 5.16B | 4.33B |
| Net Income | 3.47B | 3.67B | 4.17B | 3.78B | 2.77B |
| EPS | 1.79 | 1.85 | 1.95 | 1.68 | 1.2 |
| EBITDA | 7.07B | 7.27B | 7.66B | 7.09B | 5.76B |
| Gross Margin | 37.87% | 38.23% | 39.91% | 42.24% | 41.97% |
| Operating Margin | 36.91% | 37.30% | 38.95% | 41.20% | 40.96% |
| Net Income Margin | 23.87% | 25.03% | 28.05% | 30.19% | 26.13% |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 |